Cancer Research Annual Meeting 2010  Protein Translation and Cancer
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nakada, M.
Right arrow Articles by Sato, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nakada, M.
Right arrow Articles by Sato, H.
[Cancer Research 61, 8896-8902, December 15, 2001]
© 2001 American Association for Cancer Research


Tumor Biology

Suppression of Membrane-type 1 Matrix Metalloproteinase (MMP)-mediated MMP-2 Activation and Tumor Invasion by Testican 3 and Its Splicing Variant Gene Product, N-Tes1

Mitsutoshi Nakada, Akio Yamada, Takahisa Takino, Hisashi Miyamori, Tomoya Takahashi, Junkoh Yamashita and Hiroshi Sato2

Department of Molecular Virology and Oncology [M. N., A. Y., T. Taki., H. M., T. Taka., H. S.], Center for the Development of Molecular Target Drugs [H. S.], and Cancer Research Institute, Department of Neurosurgery, Division of Neuroscience, Graduate School of Medical Science [M. N., T. Taka., J. Y.], Kanazawa University, Ishikawa 920-0934, Japan

Using expression cloning to screen a human fetal kidney cDNA library for regulator(s) of pro-matrix metalloproteinase (MMP)-2 processing mediated by membrane-type (MT) 1 MMP, we isolated a cDNA whose product interfered with pro-MMP-2 activation. It encodes the NH2-terminal 313-amino acid region of a calcium-binding proteoglycan, testican 3, with a 3-amino acid substitution at the COOH terminus and thus was named N-Tes. N-Tes comprises a signal peptide, a unique domain, a follistatin-like domain, and a Ca2+-binding domain but lacks a COOH-terminal thyroglobulin domain and two putative glycosaminoglycan attachment sites of testican 3. Pro-MMP-2 activation by MT3-MMP was also inhibited by the coexpression of N-Tes. Immunoprecipitation analysis demonstrated direct interaction of N-Tes with either MT1-MMP or MT3-MMP. Expression of testican 1 or testican 3 but not testican 2 also inhibited pro-MMP-2 activation by either MT1-MMP or MT3-MMP. Deletion and substitution of amino acids residues in N-Tes revealed that the unique NH2-terminal domain of N-Tes is responsible for the inhibition of pro-MMP-2 activation by MT-MMPs. Expression of N-Tes and testican 3 was detected in normal brain but down-regulated in glioma tissues. Transfection of either the N-Tes or testican 3 gene into U251 glioma cells or Madin-Darby canine kidney cells transformed by erbB2 suppressed their invasive growth in collagen gel. These results suggest that both N-Tes and testican 3 would interfere with tumor invasion by inhibiting MT-MMPs.




This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
B.-H. Koo, M. Y. Park, O.-H. Jeon, and D.-S. Kim
Regulatory Mechanism of Matrix Metalloprotease-2 Enzymatic Activity by Factor Xa and Thrombin
J. Biol. Chem., August 28, 2009; 284(35): 23375 - 23385.
[Abstract] [Full Text] [PDF]


Home page
Cereb CortexHome page
T. Takahata, Y. Komatsu, A. Watakabe, T. Hashikawa, S. Tochitani, and T. Yamamori
Differential Expression Patterns of occ1-Related Genes in Adult Monkey Visual Cortex
Cereb Cortex, August 1, 2009; 19(8): 1937 - 1951.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
Y. Nishida, H. Miyamori, E. W. Thompson, T. Takino, Y. Endo, and H. Sato
Activation of Matrix Metalloproteinase-2 (MMP-2) by Membrane Type 1 Matrix Metalloproteinase through an Artificial Receptor for ProMMP-2 Generates Active MMP-2
Cancer Res., November 1, 2008; 68(21): 9096 - 9104.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Y. Itoh, N. Ito, H. Nagase, and M. Seiki
The Second Dimer Interface of MT1-MMP, the Transmembrane Domain, Is Essential for ProMMP-2 Activation on the Cell Surface
J. Biol. Chem., May 9, 2008; 283(19): 13053 - 13062.
[Abstract] [Full Text] [PDF]


Home page
Reproductive SciencesHome page
A. Ota, H. Yonemoto, A. Someya, S. Itoh, K. Kinoshita, and I. Nagaoka
Changes in Matrix Metalloproteinase 2 Activities in Amniochorions During Premature Rupture of Membranes
Reproductive Sciences, December 1, 2006; 13(8): 592 - 597.
[Abstract] [PDF]


Home page
Mol Biol EvolHome page
M. Novinec, D. Kordis, V. Turk, and B. Lenarcic
Diversity and Evolution of the Thyroglobulin Type-1 Domain Superfamily
Mol. Biol. Evol., April 1, 2006; 23(4): 744 - 755.
[Abstract] [Full Text] [PDF]


Home page
J BiochemHome page
M. Ahmad, T. Takino, H. Miyamori, T. Yoshizaki, M. Furukawa, and H. Sato
Cleavage of Amyloid-{beta} Precursor Protein (APP) by Membrane-Type Matrix Metalloproteinases.
J. Biochem., March 1, 2006; 139(3): 517 - 526.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
Y. Zhai, K. B. Hotary, B. Nan, F. X. Bosch, N. Munoz, S. J. Weiss, and K. R. Cho
Expression of Membrane Type 1 Matrix Metalloproteinase Is Associated with Cervical Carcinoma Progression and Invasion
Cancer Res., August 1, 2005; 65(15): 6543 - 6550.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. Schnepp, P. K. Lindgren, H. Hulsmann, S. Kroger, M. Paulsson, and U. Hartmann
Mouse Testican-2: EXPRESSION, GLYCOSYLATION, AND EFFECTS ON NEURITE OUTGROWTH
J. Biol. Chem., March 25, 2005; 280(12): 11274 - 11280.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
Y. Li, T. Aoki, Y. Mori, M. Ahmad, H. Miyamori, T. Takino, and H. Sato
Cleavage of Lumican by Membrane-Type Matrix Metalloproteinase-1 Abrogates This Proteoglycan-Mediated Suppression of Tumor Cell Colony Formation in Soft Agar
Cancer Res., October 1, 2004; 64(19): 7058 - 7064.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
G. Hashimoto, M. Shimoda, and Y. Okada
ADAMTS4 (Aggrecanase-1) Interaction with the C-terminal Domain of Fibronectin Inhibits Proteolysis of Aggrecan
J. Biol. Chem., July 30, 2004; 279(31): 32483 - 32491.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
H. O. Hambrock, B. Kaufmann, S. Muller, F.-G. Hanisch, K. Nose, M. Paulsson, P. Maurer, and U. Hartmann
Structural Characterization of TSC-36/Flik: ANALYSIS OF TWO CHARGE ISOFORMS
J. Biol. Chem., March 19, 2004; 279(12): 11727 - 11735.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
K. Endo, T. Takino, H. Miyamori, H. Kinsen, T. Yoshizaki, M. Furukawa, and H. Sato
Cleavage of Syndecan-1 by Membrane Type Matrix Metalloproteinase-1 Stimulates Cell Migration
J. Biol. Chem., October 17, 2003; 278(42): 40764 - 40770.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. Vannahme, N. Smyth, N. Miosge, S. Gosling, C. Frie, M. Paulsson, P. Maurer, and U. Hartmann
Characterization of SMOC-1, a Novel Modular Calcium-binding Protein in Basement Membranes
J. Biol. Chem., October 4, 2002; 277(41): 37977 - 37986.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2001 by the American Association for Cancer Research.